To evaluate the responsiveness of microvessels formed within the device, vascular endothelial growth factor (VEGF165), a known vascular permeability factor upregulated in the tumor microenvironment and other disease states, was perfused through VMO-associated vessels at 100 ng/mL for 24 h. This evidence concerns the gene VEGFA and neoplasm.